154 related articles for article (PubMed ID: 8102243)
1. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.
Gruis NA; Abeln EC; Bardoel AF; Devilee P; Frants RR; Cornelisse CJ
Br J Cancer; 1993 Aug; 68(2):308-13. PubMed ID: 8102243
[TBL] [Abstract][Full Text] [Related]
2. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p.
Jones MH; Koi S; Fujimoto I; Hasumi K; Kato K; Nakamura Y
Genes Chromosomes Cancer; 1994 Feb; 9(2):119-23. PubMed ID: 7513541
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism.
Aguiari GL; Bianchi N; Cavazzini P; Martinello R; Lovato F; Mollica G; Piva R; del Senno L
Boll Soc Ital Biol Sper; 1994 Apr; 70(4):125-8. PubMed ID: 8086156
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction allelotyping of human ovarian cancer.
Osborne RJ; Leech V
Br J Cancer; 1994 Mar; 69(3):429-38. PubMed ID: 8123469
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity detected in formalin-fixed, paraffin-embedded tissue of colorectal carcinoma using a microsatellite located within the deleted in colorectal carcinoma gene.
Huang TH; Quesenberry JT; Martin MB; Loy TS; Diaz-Arias AA
Diagn Mol Pathol; 1993 Jun; 2(2):90-3. PubMed ID: 8269282
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.
Abeln EC; Corver WE; Kuipers-Dijkshoorn NJ; Fleuren GJ; Cornelisse CJ
Br J Cancer; 1994 Aug; 70(2):255-62. PubMed ID: 8054273
[TBL] [Abstract][Full Text] [Related]
7. Linkage mapping of human chromosome 10 microsatellite polymorphisms.
Decker RA; Moore J; Ponder B; Weber JL
Genomics; 1992 Mar; 12(3):604-6. PubMed ID: 1348490
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction.
Peinado MA; Malkhosyan S; Velazquez A; Perucho M
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10065-9. PubMed ID: 1359533
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.
Allan GJ; Cottrell S; Trowsdale J; Foulkes WD
Hum Mutat; 1994; 3(3):283-91. PubMed ID: 8019564
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.
Bethwaite PB; Koreth J; Herrington CS; McGee JO
Br J Cancer; 1995 Apr; 71(4):814-8. PubMed ID: 7710949
[TBL] [Abstract][Full Text] [Related]
11. Whole chromosome 17 loss in ovarian cancer.
Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F
Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms.
Jones MH; Nakamura Y
Oncogene; 1992 Aug; 7(8):1631-4. PubMed ID: 1630822
[TBL] [Abstract][Full Text] [Related]
13. Detection of loss of heterozygosity in tumor DNA samples by PCR.
Merlo GR; Cropp CS; Callahan R; Takahashi T
Biotechniques; 1991 Aug; 11(2):166-8, 170-1. PubMed ID: 1931011
[TBL] [Abstract][Full Text] [Related]
14. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.
Zenklusen JC; Bièche I; Lidereau R; Conti CJ
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12155-8. PubMed ID: 7991599
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1.
Kelsell DP; Black DM; Bishop DT; Spurr NK
Hum Mol Genet; 1993 Nov; 2(11):1823-8. PubMed ID: 8281142
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
[TBL] [Abstract][Full Text] [Related]
18. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
19. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
Koreth J; Bethwaite PB; McGee JO
J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
Eccles DM; Brett L; Lessells A; Gruber L; Lane D; Steel CM; Leonard RC
Br J Cancer; 1992 Jan; 65(1):40-4. PubMed ID: 1310251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
